Membrane-type 1 matrix metalloproteinase-mediated progelatinase A activation in non-tumorigenic and tumorigenic humaneratinocytes

por Baumann, P, Zigrino, P, Mauch, C, Breitkreutz, D, Nischt, R
Publicado 2000

Numerical and structural aberrations in advanced neuroblastoma tumours by CGH analysis; survival correlates with chromosome 17 status

por Cunsolo, C Lo, Bicocchi, M P, Petti, A R, Tonini, G P
Publicado 2000

Autoimmunity against p53 predicts invasive cancer with poor survival in patients with an ovarian mass

por Vogl, F D, Frey, M, Kreienberg, R, Runnebaum, I B
Publicado 2000

Structures of disease-specific serum alpha-fetoprotein isoforms

por Johnson, P J, Poon, T C W, Hjelm, N M, Ho, C S, Blake, C, Ho, S K W
Publicado 2000

Differentiation enhances aminolevulinic acid-dependent photodynamic treatment of LNCaP prostate cancer cells

por Ortel, B, Sharlin, D, O'Donnell, D, Sinha, A K, Maytin, E V, Hasan, T
Publicado 2002

Decreased endothelin receptor B expression in large primary uveal melanomas is associated with early clinical metastasis and short survival

por Smith, S L, Damato, B E, Scholes, A G M, Nunn, J, Field, J K, Heighway, J
Publicado 2002

The LMCE5 unselected cohort of 25 children consecutively diagnosed with untreated stage 4 neuroblastoma over 1 year at diagnosis

por Frappaz, D, Perol, D, Michon, J, Berger, C, Coze, C, Bernard, J L, Zucker, J M, Philip, T
Publicado 2002

Butyrate down-regulates CD44 transcription and liver colonisation in a highly metastatic human colon carcinoma cell line

por Barshishat, M, Levi, I, Benharroch, D, Schwartz, B
Publicado 2002

Classification and incidence of cancers in adolescents and young adults in England 1979–1997

por Birch, J M, Alston, R D, Kelsey, A M, Quinn, M J, Babb, P, McNally, R J Q
Publicado 2002

Can a genetic signature for metastatic head and neck squamous cell carcinoma be characterised by comparative genomic hybridisation?

por Patmore, H S, Ashman James, N E, Cawkwell, L, MacDonald, A, Stafford, N D, Greenman, J
Publicado 2004

Abnormality of the DNA double-strand-break checkpoint/repair genes, ATM, BRCA1 and TP53, in breast cancer is related to tumour grade

por Ding, S L, Sheu, L F, Yu, J C, Yang, T L, Chen, B F, Leu, F J, Shen, C Y
Publicado 2004

Activity (transcription) of the genes for MLH1, MSH2 and p53 in sporadic colorectal tumours with micro-satellite instability

por Tou, S I H, Drye, E R, Boulos, P B, Hollingsworth, S J
Publicado 2004

Isolation and characterisation of a human anti-idiotypic scFv used as a surrogate tumour antigen to elicit an anti-HER-2/neu humoral response in mice

por Coelho, M, Gauthier, P, Pugnière, M, Roquet, F, Pèlegrin, A, Navarro-Teulon, I
Publicado 2004

Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers?

por Ross, P J, Ashley, S, Norton, A, Priest, K, Waters, J S, Eisen, T, Smith, I E, O'Brien, M E R
Publicado 2004

Relationship between 3p deletions and telomerase activity in non-small-cell lung cancer: prognostic implications

por Iniesta, P, González-Quevedo, R, Morán, A, García-Aranda, C, Juan, C de, Sánchez-Pernaute, A, Torres, A, Díaz-Rubio, E, Balibrea, J L, Benito, M
Publicado 2004

Thyroid carcinoma after Chernobyl latent period, morphology and aggressiveness

por Williams, E D, Abrosimov, A, Bogdanova, T, Demidchik, E P, Ito, M, LiVolsi, V, Lushnikov, E, Rosai, J, Sidorov, Yu, Tronko, M D, Tsyb, A F, Vowler, S L, Thomas, G A
Publicado 2004

Cost study of metal stent placement vs single-dose brachytherapy in the palliative treatment of oesophageal cancer

por Polinder, S, Homs, M Y V, Siersema, P D, Steyerberg, E W
Publicado 2004

Cytomegalovirus, Epstein–Barr virus and risk of breast cancer before age 40 years: a case–control study

por Richardson, A K, Cox, B, McCredie, M R E, Dite, G S, Chang, J-H, Gertig, D M, Southey, M C, Giles, G G, Hopper, J L
Publicado 2004

Molecular alterations in apoptotic pathways after PKB/Akt-mediated chemoresistance in NCI H460 cells

por Hövelmann, S, Beckers, T L, Schmidt, M
Publicado 2004

Genomic analysis reveals RhoC as a potential marker in hepatocellular carcinoma with poor prognosis

por Wang, W, Yang, L-Y, Huang, G-W, Lu, W-Q, Yang, Z-L, Yang, J-Q, Liu, H-L
Publicado 2004